参考文献/References:
[1]BATEMAN ED, HURD SS,BARNES PJ,et al.Global strategy for asthma management and prevention:GINA executive summary[J].The European respiratory journal,31(1),143-178.
[2]KURUVILLA ME,VANIJCHAROENKARN K,SHIH JA,et al.Epidemiology and risk factors for asthma[J].Respiratory Medicine,2019,149:16-22.
[3]喻晓,石克华,折哲,等.咳喘散穴位敷贴治疗支气管哮喘慢性持续期临床疗效观察[J].辽宁中医杂志,2012,39(5):876-878.
[4]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志,2020,43(12):1023-1048.
[6]郑筱萸.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2002:51-54.
[9]RU JL,LI P,WANG JN,et al.TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J].Journal of Cheminformatics,2014,6:13.
[10]XU HY,ZHANG YQ,LIU ZM,et al.ETCM:an encyclopaedia of traditional Chinese medicine[J].Nucleic Acids Research,2019,47(D1):D976-D982.
[11]BUSSE WW,KRAFT M,RABE KF,et al.Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation[J].The European Respiratory Journal,2021,58(2):2003393.
[12]MANDLIK DS,MANDLIK SK.New perspectives in bronchial asthma:pathological,immunological alterations,biological targets,and pharmacotherapy[J].Immunopharmacology and Immunotoxicology,2020,42(6):521-544.
[13]KURUVILLA ME,LEE FEH,LEE GB.Understanding asthma phenotypes,endotypes,and mechanisms of disease[J].Clinical Reviews in Allergy & Immunology,2019,56(2):219-233.
[14]BERNSTEIN DI.ABCs of asthma[J].Clinical Cornerstone,2008,8(4):9-25.
[15]PAVN-ROMERO GF,SERRANO-PREZ NH,GARCA-SNCHEZ L,et al.Neuroimmune pathophysiology in asthma[J].Frontiers in Cell and Developmental Biology,2021,9:663535.
[16]KIM JS,KANG JY,HA JH,et al.Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients[J].The Journal of Asthma:Official Journal of the Association for the Care of Asthma,2013,50(7):712-717.
[17]NTONTSI P,PHOTIADES A,ZERVAS E,et al.Genetics and epigenetics in asthma[J].International Journal of Molecular Sciences,2021,22(5):2412.
[18]RUSSELL RJ,BRIGHTLING C.Pathogenesis of asthma:implications for precision medicine[J].Clinical Science,2017,131(14):1723-1735.
[19]BUSSE WW,KRAFT M,RABE KF,et al.Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation[J].The European Respiratory Journal,2021,58(2):2003393.
[20]SAITO A,HORIE M,NAGASE T.TGF-β signaling in lung health and disease[J].International Journal of Molecular Sciences,2018,19(8):2460.
[21]庞亚蓉,席建宏,王志旺,等.磷脂酰肌醇3激酶/蛋白激酶B(PI3K/Akt)信号通路参与哮喘气道炎症反应的研究现状[J].中国临床药理学杂志,2021,37(14):1897-1901.
[22]LI H,WANG Z,ZHANG J,et al.Feifukang ameLiorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway[J].BMC Complement Alten Med,2018,18(1):234.
[23]HU SHILING,WANG JUE,BAI HAOYUN,et al.Secreted phosphoprotein 1 regulates natural compound 3′,4′,5,7-tetrahydroxyflavone to inhibit mast cell-mediated allergic.inflammationJournal[J].Immunopharmacology and immunotoxicology.Volume,Issue.2023,PP11-13.
[24]王蕊,刘军,杨大宇,等.白芷化学成分与药理作用研究进展[J].中医药信息,2020,37(2):123-128.
[25]PARK SY,SEETHARAMAN R,KO MJ,et al.Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cells[J].International Immunopharmacology,2014,19(2):253-261.
[26]YUAN J,LIU R,MA Y,et al.Curcumin attenuates airway inflammation and airway remolding by inhibiting NF-κB signaling and COX-2 in cigarette Smoke-induced COPD mice[J].Inflammation,2018,41(5):1804-14.
[27]HU YANCHAO,FAN YAJIE,ZHANG CHUNYAN,et al.Palmitic acid inhibits vascular smooth muscle cell switch to synthetic phenotype via upregulation of miR-22 expression[J].Aging,2022,14(19):8046-8060.
[28]陈桂英,刘国慧,姜雪,等.厚朴多糖通过调控调控PI3K/Akt信号通路对哮喘大鼠气道重塑的作用[J].中成药,2024,46(4):1332-1336.
[29]毛蜀,何密斯,刘桂元,等.姜黄素对髓母细胞瘤PI3K/Akt信号通路的作用[J].第三军医大学学报,2013,35(6):518-522.
[30]马春兰,张宝亮,刘晓明.雷公藤多苷抑制PI3K/AKT信号通路对肺腺癌细胞迁移和血管形成的影响[J].安徽医药,2022,26(2):235-238.
[31]吴骞,丁榆德,程刚.山柰酚通过PI3K/Akt信号通路对口腔癌细胞增殖、侵袭及迁移的影响[J].中药材,2020,43(12):3045-3049.
[32]雷俊.牛蒡子苷元抑制TLR4/TRAF6/NF-κB信号通路对哮喘模型大鼠气道重塑和Th1/Th2免疫平衡的影响[J].免疫学杂志,2023,39(1):12-20.
[33]赖根祥,朱桂东,何慧明.栀子苷通过抑制TLR4/NF-κB信号通路减轻睡眠剥夺大鼠认知功能障碍[J].中国病理生理杂志,2020,36(10):1810-1817.
[34]MA B,ATHARI SS,MEHRABI NASAB E.et al.PI3K/AKT/mTOR and TLR4/MyD88/NF-κB Signaling Inhibitors Attenuate Pathological Mechanisms of Allergic Asthma[J].Inflammation,2021(44):1895-1907.
[35]吕川,朱慧志,刘向国,等.基于IL-6/JAK2/STAT3信号轴研究阳和平喘颗粒调控哮喘大鼠气道重塑作用机制[J].海南医学院学报,2024,30(1):15-20,28.
[36]张文斌,王杰,王玮,等.健脾益肺汤抑制NF-κB/STAT3信号通路改善哮喘模型大鼠气道炎症及气道重塑作用研究[J].中国中医急症,2019,28(5):806-808+832.
[37]付昆,杨艳,陆一菱,等.基于IL-6/STAT3和IL-2/STAT5信号通路探讨伏九贴敷药物调控Th17/Treg免疫平衡的抗哮喘作用机制[J].中药新药与临床药理,2024,35(1):26-34.
[38]陈淑珍.中药单体治疗哮喘的作用与机制研究进展[J].中医药学报,2021,49(10):89-93.[39]周旋,谭志团,任翼,等.柚皮素通过抑制NF-κB信号通路减轻哮喘大鼠气道炎症反应[J].天津医药,2021,49(5):483-489.
相似文献/References:
[1]杨继 王强 **张垚.祛风解痉法治疗支气管哮喘慢性持续期探究[J].现代中医药,2018,(06):095.[doi:10.13424/j.cnki.mtcm.2018.06.033]
Yang Ji Wang Qiang.Treatment of Chronic Persistent Bronchial Asthma
by Dispelling Pathogenic Wind for Resolving Convulsion[J].Modern Traditional Chinese Medicine,2018,(05):095.[doi:10.13424/j.cnki.mtcm.2018.06.033]
[2]张晶 吴晓晨 张家旺 谢雨婕 钟华胜.全真一气汤对肾气虚型哮喘大鼠转录因子FOXP3/RORγt及Th17/Treg免疫失衡的影响[J].现代中医药,2023,(06):096.[doi:10.13424/j.cnki.mtcm.2023.06.020]